Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When redeeming rewards, several factors can influence your choices. Learn what to consider to ensure you get the best value for your points.
17,088 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Salesforce just delivered a solid quarter with revenue and adjusted earnings topping expectations and a $50 billion b...
Bold claims about doubling your money tempt investors. This guide explains realistic paths to potential outsized gain...
Miami's Dolphins stunned the league by agreeing to a record $99.2 million exit package for a veteran player. The move...
This analysis breaks down the Q4 2025 earnings transcript for quest resource (qrhc), highlighting revenue, margins, a...
Five high-yield dividend stocks trading under $20 are drawing renewed interest as rate volatility persists, offering ...
Starting July 2026, the federal loan cap for professional programs changes how families fund education. Clark Howard’...
As Cardano prepares to roll out its Midnight privacy network this week, the cardano shorts spike highest reading sinc...
A notable stake in TowneBank marks a strategic bet by Patriot Financial Partners. This article breaks down what the i...
A high-profile crypto case underscores the risk for athletes and fans alike. This guide explains how seed phrases are...
With rates steady and mobility rising, financial advisors contend that the decision to rent or buy depends on your li...